Search results
AstraZeneca’s Tagrisso gains approval in Canada for NSCLC
Pharmaceutical Technology· 1 hour agoPatients treated with the combination therapy experienced a median progression-free survival (PFS) ...
Patients treated with the combination therapy experienced a median progression-free survival (PFS) ...